MORAVEK BIOCHEMICALS, INC

MORAVEK BIOCHEMICALS, INC specializes in the manufacturing of radiolabeled biological products for specialized medical and research applications, with demonstrated expertise in the synthesis and purification of radioisotope-conjugated pigments. Their core capability centers on the precise chemical labeling of complex organic compounds—such as Pigment Red 22—with therapeutic or diagnostic radioisotopes, enabling targeted imaging or treatment protocols. This requires advanced expertise in radiochemistry, molecular conjugation techniques, aseptic processing, and quality control under cGMP conditions. The company’s technical differentiation lies in its ability to produce stable, high-specific-activity radiolabeled biomolecules with minimal impurity profiles, a critical requirement for clinical and preclinical use. Their work supports applications in nuclear medicine, molecular imaging, and targeted radionuclide therapy development. The contractor has delivered products to the Department of Health and Human Services, indicating direct engagement in federally funded biomedical research or therapeutic development programs. This relationship suggests alignment with NIH or CDC initiatives involving novel radiopharmaceuticals or labeled tracers for biological studies. Their engagement appears focused on niche, high-precision manufacturing rather than broad-scale production. The primary NAICS code, 325414, reflects active participation in the biological product manufacturing sector, specifically the production of non-diagnostic radiolabeled compounds. This positions MORAVEK BIOCHEMICALS as a specialized supplier within the radiopharmaceutical supply chain, serving research institutions and government laboratories requiring custom-labeled biochemical agents. As a small business structured as a 2L entity based in Brea, California, the company operates with a focused, agile production model. While it currently holds no formal government certifications, its ability to deliver compliant radiolabeled biological products suggests adherence to federal quality and safety standards required for HHS procurement. Its geographic location supports access to West Coast research hubs and regulatory infrastructure.